Draft Guidance on Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA: Narrow Therapeutic Index Drugs¶
U.S. Food and Drug Administration, Center for Drug Evaluation and Research. (2014). Draft Guidance on Bioequivalence Studies with Pharmacokinetic Endpoints for Drugs Submitted Under an ANDA: Narrow Therapeutic Index Drugs: Narrow Therapeutic Index Drugs.
Cited by¶
1 citation across 1 artifact.
Each citation links to the sentence it supports in the citing article.
Primes¶
- Therapeutic Window
- The clarity extends to regulatory thinking: narrow-therapeutic-window drugs (NTWDs) are a formal regulatory category, codified by the FDA (2014) in its bioequivalence guidance for narrow-therapeutic-index drugs, requiring special handling (therapeutic drug monitoring, dose adjustment protocols, patient education), whereas wide-window drugs tolerate standard dosing.
This sourceFDA Office of Generic Drugs. Codifies the regulatory category of narrow-therapeutic-index (NTI) drugs and the heightened bioequivalence and monitoring requirements that follow from a narrow therapeutic window.
- The clarity extends to regulatory thinking: narrow-therapeutic-window drugs (NTWDs) are a formal regulatory category, codified by the FDA (2014) in its bioequivalence guidance for narrow-therapeutic-index drugs, requiring special handling (therapeutic drug monitoring, dose adjustment protocols, patient education), whereas wide-window drugs tolerate standard dosing.
Verification¶
Does it exist? Not checked yet. This entry carries no identifier to resolve. It was extracted from the citation as written in the article, normalized, and deduplicated against the rest of the registry.
Does it back the claim? Not recorded. The single citation of this work carries no recorded support check.
Was it audited? Yes. A second, independent pass read the citation against the article text and recorded a verdict.
Support is checked per citation rather than per work — the same source can be cited soundly in one article and wrongly in another. Per-citation recording began recently, so a citation with no recorded check is a gap in the record rather than evidence it went unchecked.
See how references were verified.
Registry ID ref:cce5c894e944 · see in the full table